This session merges the foresight of investment trends with the strategic acumen required to de-risk synthetic biology ventures. Attendees will engage with leading investment firms and seasoned biotech entrepreneurs in a roundtable discussion that dissects the current investment climate while charting a clear course for making SynBio startups investment-ready. Experts will shed light on emerging trends, identify sectors attracting the keenest interest, and provide actionable strategies for SynBio entrepreneurs to mitigate risks and attract funding. From understanding the intricacies of regulatory landscapes to mastering the art of communicating value propositions, this session promises a deep dive into how startups can align with investor expectations and navigate the complexities of capital acquisition in a landscape ripe with opportunity and challenge. Viewers will leave equipped with knowledge and a framework for action that marries financial savvy with scientific innovation, priming their ventures for success in a competitive market.